| Prevalence and symptomatic burden of diagnosed endometriosis in the United States: national estimates from a cross-sectional survey of 59,411 women MJ Fuldeore, AM Soliman Gynecologic and obstetric investigation 82 (5), 453-461, 2017 | 280 | 2017 |
| The direct and indirect costs associated with endometriosis: a systematic literature review AM Soliman, H Yang, EX Du, C Kelley, C Winkel Human reproduction 31 (4), 712-722, 2016 | 224 | 2016 |
| Elagolix for heavy menstrual bleeding in women with uterine fibroids WD Schlaff, RT Ackerman, A Al-Hendy, DF Archer, KT Barnhart, ... New England Journal of Medicine 382 (4), 328-340, 2020 | 171 | 2020 |
| The burden of endometriosis symptoms on health-related quality of life in women in the United States: a cross-sectional study AM Soliman, KS Coyne, E Zaiser, J Castelli-Haley, MJ Fuldeore Journal of Psychosomatic Obstetrics & Gynecology 38 (4), 238-248, 2017 | 156 | 2017 |
| The effect of endometriosis symptoms on absenteeism and presenteeism in the workplace and at home AM Soliman, KS Coyne, KS Gries, J Castelli-Haley, MC Snabes, ... Journal of managed care & specialty pharmacy 23 (7), 745-754, 2017 | 147 | 2017 |
| Real-world evaluation of direct and indirect economic burden among endometriosis patients in the United States AM Soliman, E Surrey, M Bonafede, JK Nelson, J Castelli-Haley Advances in therapy 35, 408-423, 2018 | 138 | 2018 |
| Factors associated with time to endometriosis diagnosis in the United States AM Soliman, M Fuldeore, MC Snabes Journal of women's health 26 (7), 788-797, 2017 | 135 | 2017 |
| Impact of endometriosis on life-course potential: a narrative review SA Missmer, FF Tu, SK Agarwal, C Chapron, AM Soliman, S Chiuve, ... International Journal of General Medicine, 9-25, 2021 | 124 | 2021 |
| Long-term outcomes of elagolix in women with endometriosis: results from two extension studies E Surrey, HS Taylor, L Giudice, BA Lessey, MS Abrao, DF Archer, ... Obstetrics & Gynecology 132 (1), 147-160, 2018 | 119 | 2018 |
| The direct and indirect costs of uterine fibroid tumors: a systematic review of the literature between 2000 and 2013 AM Soliman, H Yang, EX Du, SS Kelkar, C Winkel American journal of obstetrics and gynecology 213 (2), 141-160, 2015 | 117 | 2015 |
| Impact of endometriosis diagnostic delays on healthcare resource utilization and costs E Surrey, AM Soliman, H Trenz, C Blauer-Peterson, A Sluis Advances in therapy 37, 1087-1099, 2020 | 104 | 2020 |
| Healthcare utilization and costs in women diagnosed with endometriosis before and after diagnosis: a longitudinal analysis of claims databases M Fuldeore, H Yang, EX Du, AM Soliman, EQ Wu, C Winkel Fertility and sterility 103 (1), 163-171, 2015 | 97 | 2015 |
| Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 1 trial LE Kristensen, M Keiserman, K Papp, L McCasland, D White, W Lu, ... Annals of the Rheumatic Diseases 81 (2), 225-231, 2022 | 92 | 2022 |
| Risk of developing comorbidities among women with endometriosis: a retrospective matched cohort study ES Surrey, AM Soliman, SJ Johnson, M Davis, J Castelli-Haley, ... Journal of women's health 27 (9), 1114-1123, 2018 | 88 | 2018 |
| Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study DF Archer, EA Stewart, RI Jain, RA Feldman, AS Lukes, JD North, ... Fertility and sterility 108 (1), 152-160. e4, 2017 | 87 | 2017 |
| Prevalence, symptomatic burden, and diagnosis of endometriosis in Canada: cross-sectional survey of 30 000 women S Singh, AM Soliman, Y Rahal, C Robert, I Defoy, P Nisbet, N Leyland Journal of Obstetrics and Gynaecology Canada 42 (7), 829-838, 2020 | 76 | 2020 |
| Impact of uterine fibroid symptoms on health-related quality of life of US women: evidence from a cross-sectional survey AM Soliman, MK Margolis, J Castelli-Haley, MJ Fuldeore, CD Owens, ... Current medical research and opinion 33 (11), 1971-1978, 2017 | 68 | 2017 |
| Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial A Östör, F Van den Bosch, K Papp, C Asnal, R Blanco, J Aelion, ... Annals of the Rheumatic Diseases 81 (3), 351-358, 2022 | 67 | 2022 |
| Optimal Diabetes Care Outcomes Following Face-to-Face Medication Therapy Management Services AR Brummel, AM Soliman, AM Carlson, DR Oliveira Population Health Management 16 (1), 28-34, 2013 | 66 | 2013 |
| Patient-reported prevalence and symptomatic burden of uterine fibroids among women in the United States: findings from a cross-sectional survey analysis MJ Fuldeore, AM Soliman International journal of women's health, 403-411, 2017 | 65 | 2017 |
Kim Papp and K Papp and K A Papp a...Probity Medical ResearchVerified email at probitymedical.com
